Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Vaccine|December 28, 2017
Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Hana M El Sahly, Sarah George, et al.The Journal of Infectious Diseases|August 12, 2025
Low intrinsic killing activity and no impact of its positivity on phase 3 pneumococcal vaccine adult studiesWeifeng Xu, Joseph Antonello, Jennifer Nguyen, et al.Investigative Ophthalmology & Visual Science|November 1, 2011
Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae KeratitisErin W Norcross, Melissa E Sanders, Quincy C Moore, et al.Vaccine|January 9, 2020
Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individualsSarah Sterrett, Binghao J Peng, Robert L Burton, et al.Vaccine|November 9, 2020
Assignment of opsonic values to pneumococcal reference serum 007sp and a second pneumococcal OPA calibration serum panel (Ewha QC sera panel B) for 11 serotypesRobert L Burton, Han Wool Kim, Soyoung Lee, et al.The Pediatric Infectious Disease Journal|March 18, 2010
Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infantsCarl T D'Angio, Roy J Heyne, T Michael O'Shea, et al.Clinical and Vaccine Immunology : CVI|November 19, 2010
Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference seraCharles E Rose, Sandra Romero-Steiner, Robert L Burton, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2012
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary diseaseMark T Dransfield, Sarah Harnden, Robert L Burton, et al.Pageof 3